Literature DB >> 26885119

Interaction between peroxisome proliferator- activated receptor gamma polymorphism and overweight on diabetic retinopathy in a Chinese case-control study.

Yan Wang1, Xin-Hua Wang1, Ruo-Xi Li1.   

Abstract

BACKGROUND: Peroxisome proliferator-activated receptors γ (PPAR γ) and overweight were both associated with diabetic retinopathy (DR), so the aim of this study was to investigate the association of four single nucleotide polymorphisms (SNPs) of PPAR γ with DR and additional role of gene-BMI interaction.
METHODS: A total of 500 patients with T2DM (236 men, 264 women), with a mean age of 54.3 ± 15.8 years old, were selected, including 247 diabetic retinopathy patients and 253 controls. Four SNPs were selected for genotyping in the case-control study: rs1805192, rs709158, rs3856806, rs4684847. Logistic regression model was used to examine the interaction between SNP and overweight on DR, odds ratio (OR) and 95% confident interval (95% CI) were calculated.
RESULTS: The carriers of C allele of the rs1805192 polymorphism revealed decreased DR risk than those with Pro/Pro variants (Pro/Ala+Ala/Ala versus Pro/Pro, adjusted OR (95% CI)=0.86 (0.65-0.96), P=0.012), after adjusting for covariates. We also found that obese subjects with Pro/Ala or Ala/Ala variants genotype have lowest DR risk, compared to obese subjects with Pro/Pro genotype or non- obese subjects with Pro/Ala or Ala/Ala (OR=0.40, 95% CI=0.32-0.63), after covariates adjustment.
CONCLUSIONS: Our results support an important association between rs1805192 minor allele (Ala allele) of PPAR γ and DR, the interaction analysis shown a combined effect of Ala- BMI interaction on DR.

Entities:  

Keywords:  Diabetic retinopathy; PPAR; interaction; overweight; polymorphism

Year:  2015        PMID: 26885119      PMCID: PMC4723964     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  26 in total

Review 1.  Peroxisome proliferator-activated receptor gamma: the more the merrier?

Authors:  C A Argmann; T-A Cock; J Auwerx
Journal:  Eur J Clin Invest       Date:  2005-02       Impact factor: 4.686

2.  The gene polymorphisms of UCP1 but not PPAR γ and TCF7L2 are associated with diabetic retinopathy in Chinese type 2 diabetes mellitus cases.

Authors:  Yue Zhang; Nana Meng; Zhiping Lv; Hao Li; Yi Qu
Journal:  Acta Ophthalmol       Date:  2014-10-01       Impact factor: 3.761

3.  Relationship of diabetic retinopathy with coronary artery disease in Asian Indians with type 2 diabetes: the Chennai Urban Rural Epidemiology Study (CURES) Eye Study--3.

Authors:  Rajendra Pradeepa; Jayagopi Surendar; Karunakaran Indulekha; Sundarapandi Chella; Ranjit Mohan Anjana; Viswanathan Mohan
Journal:  Diabetes Technol Ther       Date:  2014-11-06       Impact factor: 6.118

4.  Correlation of C-reactive protein and body mass index with diabetic retinopathy in Indian population.

Authors:  Dipayan Sen; Sambuddha Ghosh; Debesh Roy
Journal:  Diabetes Metab Syndr       Date:  2014-05-29

5.  Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial.

Authors:  Michael W Steffes; Shalamar Sibley; Melissa Jackson; William Thomas
Journal:  Diabetes Care       Date:  2003-03       Impact factor: 19.112

6.  The correlation of common carotid arterial diameter with atherosclerosis and diabetic retinopathy in patients with type 2 diabetes mellitus.

Authors:  Michiaki Miyamoto; Kazuhiko Kotani; Kenta Okada; Yasutomo Fujii; Kei Konno; Shun Ishibashi; Nobuyuki Taniguchi
Journal:  Acta Diabetol       Date:  2011-04-29       Impact factor: 4.280

7.  Pancreatic beta-cell mass in European subjects with type 2 diabetes.

Authors:  J Rahier; Y Guiot; R M Goebbels; C Sempoux; J C Henquin
Journal:  Diabetes Obes Metab       Date:  2008-11       Impact factor: 6.577

8.  Body mass index and retinopathy in Asian populations with diabetes mellitus.

Authors:  David Rooney; Weng Kit Lye; Gavin Tan; Ecosse L Lamoureux; Mohammad Kamran Ikram; Ching-Yu Cheng; Neelam Kumari; Ying Feng Zheng; Paul Mitchell; Jie Jin Wang; Tien Y Wong; Charumathi Sabanayagam
Journal:  Acta Diabetol       Date:  2014-06-01       Impact factor: 4.280

9.  Fasting plasma C-peptide and micro- and macrovascular complications in a large clinic-based cohort of type 1 diabetic patients.

Authors:  Francesco Panero; Giulia Novelli; Chiara Zucco; Paolo Fornengo; Massimo Perotto; Olivia Segre; Giorgio Grassi; Paolo Cavallo-Perin; Graziella Bruno
Journal:  Diabetes Care       Date:  2008-11-18       Impact factor: 17.152

10.  Impact of C-peptide preservation on metabolic and clinical outcomes in the Diabetes Control and Complications Trial.

Authors:  John M Lachin; Paula McGee; Jerry P Palmer
Journal:  Diabetes       Date:  2013-10-02       Impact factor: 9.461

View more
  2 in total

1.  Association between PPAR-γ2 gene polymorphisms and diabetic retinopathy risk: a meta-analysis.

Authors:  Xue-Feng Li; Guang-Bin Jiang; Shi-Yan Cheng; Ya-Feng Song; Cai Deng; Yu-Ming Niu; Jun-Wei Cai
Journal:  Aging (Albany NY)       Date:  2021-02-01       Impact factor: 5.682

Review 2.  Association of Peroxisome Proliferator-Activated Receptors (PPARs) with Diabetic Retinopathy in Human and Animal Models: Analysis of the Literature and Genome Browsers.

Authors:  Špela Tajnšek; Danijel Petrovič; Mojca Globočnik Petrovič; Tanja Kunej
Journal:  PPAR Res       Date:  2020-03-03       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.